Molecular Imaging Insight - June 2008 - (Page 11)

and pediatric imaging—causing competition for camera time, with referring physicians regretting when they have to send patients with clear indications for SPECT/CT to conventional SPECT. By accelerating the acquisition time of cardiac procedures (which still represent 50 percent of the studies), IQ•SPECT frees up the agenda for SPECT/CT. Hybrid SPECT/CT: Beyond perfusion “Myocardial perfusion SPECT is a good tool for visualization of perfusion changes,” says Torsten Kuwert, MD, director and chair of clinical nuclear medicine at the University of ErlangenNuremberg in Germany. “Its prognostic value is high. On the other hand, advances are possible. SPECT does not allow physicians to visualize vessels or morphology. Nor does it provide a calcium score.” Hybrid SPECT/CT cameras could rise to the challenge by providing a means to visualize morphology and perfusion in a single imaging session. Raising the bar in well-established myocardial perfusion SPECT imaging evaluations using hybrid SPECT/CT imaging can enable the addition of calcium scoring, for evaluating a patient’s risk of developing coronary artery disease. Adding the 30-second CT to the SPECT study adds the assessment of the buildup of calcium in the coronary arteries to the standard ischemia evaluation. Because many heart attacks occur in patients without obvious signs or risk factors, calcium scoring can add independent information in the detection of coronary artery disease. The acquisition dilemma “The major limitation of SPECT is its acquisition time,” says James Corbett, MD, director of cardiovascular nuclear medicine at University of Michigan in Ann Arbor. “It takes from 12 to 20 minutes to acquire images, which can be a long time for patients, particularly those who are heavy, in heart failure, or claustrophobic.” The lengthy acquisition time can impact overall image quality. Uncomfortable patients tend to move, and those who are short of breath may take deep breaths causing misregistration between SPECT and CT. Typically, the longer the procedure time, the greater the likelihood that patients will be uncomfortable and breathe deeply. Both patient movement and deep breathing detract from the final image quality and potentially from diagnostic accuracy. “The ability to acquire images more rapidly should be an advantage for all patients,” explains Corbett. Not only does it translate into improved image quality, but it also facilitates a less stressful, more comfortable patient experience. More rapid image acquisition could deliver benefits beyond improved image quality. As reimbursement for myocardial perfusion SPECT is gradually diminished, any additional efficiency in the camera would allow the provider to image additional patients. A practice with access to a faster camera would enjoy a great advantage over its competitors because the faster SPECT camera could accommodate two or three patients in the same amount of camera time as a current generation system can image one patient. “Outpatient practices might be able to purchase fewer systems, or serve more patients with fewer systems,” says Corbett. The financial benefits of a faster camera are equally appealing on the inpatient side. Patients with acute coronary syndromes and other unstable conditions generally require a nurse to accompany them during SPECT examinations. “A patient may have to be in the nuclear medicine department for several hours for stress and, if appropriate, rest SPECT studies. It adds up to a significant amount of nursing time and studies. In some cases, some one-day studies turn into two-day studies for logistical reasons,” Corbett says. Shorter studies minimize the impact on nursing staff and often reduce the length of hospital stay. Although growth in cardiac SPECT has flattened in recent years, demographic factors point to a potential surge in demand for the study. The obesity epidemic and the aging population could make for a perfect storm with more patients requiring cardiac SPECT imaging in the coming years. Sites equipped with systems capable of improved patient throughput could enjoy a competitive advantage. MolecularImaging.net The tracer angle “Nuclear cardiology lacks new tracers, especially agents to enable visualization of atherosclerosis in the vessel walls,” says Kuwert. Approximately 50 percent of myocardial infarctions occur in arteries without a major occlusion before the event. The culprit is vulnerable plaque, which cannot be identified by coronary angiography. Cardiologists, thus, lack the right tool to make an accurate diagnosis. The challenge could be solved via a SPECT-specific radiopharmaceutical agent capable of identifying unstable plaque. On the horizon Siemens IQ•SPECT technology represents the next step in SPECT and hybrid SPECT/CT imaging. The technology will enable SPECT and SPECT/CT cameras to a comprehensive cardiac workup including perfusion, CT attenuation correction and calcium scoring in as few as five minutes: four minutes for the SPECT acquisition and one minute for re-positioning and the CT study. IQ•SPECT technology is achieved through a specially designed “smart” collimator that magnifies the heart. Typically, SPECT data are obtained through mechanically centered detector rotation, where organ-specific magnification cannot be achieved. The flexible mechanics of the Siemens’ Symbia S and T gantries allow an organ-centric detector rotation that can zeroin on the organ of interest; in this case, the heart. Because nuclear cardiology is such a mature specialty, any new technology needs to integrate with current systems, and IQ•SPECT is designed to connect with all standard reading and reporting packages to allow a seamless user experience. Siemens expects to unveil the technology in 2009. This new tool for cardiology is a great leap forward. With IQ•SPECT, cardiologists can look forward to improvements in image quality, patient care and the bottom line. June 2008 | Molecular Imaging Insight 11 http://MolecularImaging.net

Table of Contents Feed for the Digital Edition of Molecular Imaging Insight - June 2008

Molecular Imaging Insight - June 2008 Contents NOPR: A Landmark Study Cover Story: Evidence-based Medicine Points to Wider Role for Molecular Imaging in Patient Care NOPR Delivers Evidence for Expanded PET Use in Oncology Imaging The Balancing Act Nuclear Cardiology’s Next Step Molecular Imaging Training Gaining Traction SPECT/CT’s Role in Post-Transplant Infection Imaging Clinical Study Digest : Heart Disease & Metastatic Breast, Gastric and Head & Neck Cancer

Molecular Imaging Insight - June 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.